The role of IDH1 as prognostic marker is controversial; literature data demonstrated that IDH1 mutations correlated with good prognosis in brain tumors, such as glioma, glioblastoma and anaplastic astrocytoma [19]. This evidence concerns the gene IDH1 and anaplastic astrocytoma.